Landos Biopharma, Inc. Quarterly Common Stock, Shares, Outstanding from Q4 2020 to Q1 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Landos Biopharma, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2020 to Q1 2024.
  • Landos Biopharma, Inc. Common Stock, Shares, Outstanding for the quarter ending March 31, 2024 was 3.12M shares, a 90% decline year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 3.12M -28.1M -90% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 3.12M -909K -22.6% Dec 31, 2023 10-Q 2024-05-09
Q3 2023 3.12M -37.1M -92.3% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 3.12M -37.1M -92.3% Jun 30, 2023 10-Q 2023-08-09
Q1 2023 31.2M -9.09M -22.6% Mar 31, 2023 10-Q 2023-05-12
Q4 2022 4.03M -36.2M -90% Dec 31, 2022 10-K 2024-03-21
Q3 2022 40.3M +27.5M +215% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 40.3M +354K +0.89% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 40.3M +388K +0.97% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 40.3M +27.5M +215% Dec 31, 2021 10-K 2023-03-23
Q3 2021 12.8M Sep 30, 2021 10-Q 2021-11-15
Q2 2021 39.9M Jun 30, 2021 10-Q 2021-07-29
Q1 2021 39.9M Mar 31, 2021 10-Q 2021-05-17
Q4 2020 12.8M Dec 31, 2020 10-K 2022-03-24
* An asterisk sign (*) next to the value indicates that the value is likely invalid.